ATS(ATS) - 2026 Q3 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Order bookings for Q3 were $821 million, up almost 12% sequentially and down 7% compared to Q3 last year [10][16] - Q3 revenues reached $761 million, representing a 16.7% increase year-over-year, driven by organic growth of 12.6% and a 4.1% benefit from foreign exchange [10][17] - Adjusted earnings from operations in Q3 were $80 million, a 21.6% increase from Q3 last year [10][17] - Gross margin for Q3 was 29.6%, a decrease of 111 basis points from the previous year due to program mix [17] - The company ended the quarter with an order backlog of approximately $2.1 billion [11][18] Business Line Data and Key Metrics Changes - In life sciences, order backlog was $1.1 billion, with revenues for the quarter at $391 million, the second highest in ATS's history [11][12] - In food and beverage, Q3 order backlog was CAD 203 million, with strong funnel activity driven by brand recognition [12] - Energy sector order backlog reached a record CAD 296 million, up 87% over Q3 last year, driven by refurbishment and life extension projects for nuclear reactors [12][13] - Consumer products backlog hit a record CAD 321 million, supported by a large enterprise warehouse packaging automation program [14] Market Data and Key Metrics Changes - The company reported strong demand in life sciences, particularly in radiopharmaceuticals and GLP-1 auto-injectors [11][12] - The energy sector is experiencing growth due to refurbishment projects and new build programs, including both large-scale reactors and small modular reactors (SMRs) [12][13] - The transportation segment continues to reflect smaller-scale opportunities, with a cautious approach to pursuing larger projects [68] Company Strategy and Development Direction - The company is focused on margin expansion, capital allocation, and leveraging its strong lean operating system [5][8] - Recent leadership appointments aim to strengthen operational capabilities in key end markets [6][7] - The strategy includes embedding the growing services business within operating units to enhance accountability and customer alignment [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to execute and deliver long-term value, despite a dynamic macro environment [20] - The company has not been materially impacted by tariffs and continues to adapt to customer needs across different geographies [20] - Management remains optimistic about the outlook for ATS, emphasizing the potential for margin expansion and capital efficiency [29] Other Important Information - The company incurred CAD 5.5 million in restructuring costs during the quarter, with total costs expected to be approximately CAD 20 million [19] - Cash flows from operating activities were CAD 115 million, with non-cash working capital as a percentage of revenues improving to 16.4% [21] - Capital expenditures for the quarter were $16.6 million, with expectations for fiscal 2026 CapEx between $70 million and $90 million [21] Q&A Session Summary Question: Doug's priorities in the first 90 days - Doug highlighted a focus on core end markets, margin expansion potential, and disciplined capital deployment [28][29] Question: Connection between margin improvement and gross margin change - Anne explained that gross margin changes reflect program execution and backlog dynamics, with ongoing opportunities for improvement [34][35] Question: Outlook for nuclear and life sciences segments - Anne discussed strong backlog in nuclear and ongoing growth in life sciences, with new orders contributing to the positive outlook [39][40] Question: Capital allocation and working capital targets - Doug indicated that while it's premature to set new targets, the company is focused on improving working capital efficiency and considering M&A opportunities [44][46] Question: Impact of reshoring and tariffs on business - Doug noted that while reshoring discussions are prevalent, the primary driver for capacity expansion is the increased demand for therapeutics [65] Question: Transportation segment outlook - Doug mentioned a cautious approach to the transportation segment, focusing on targeted niches rather than large-scale projects [68]